Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

Abstract excerpt

Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated diarrhea, is regarded as one of the most common healthcare-associated bacterial infections worldwide. Due to the emergence of hypervirulent strains, development of new therapeutic methods for C. difficile infection (CDI) has become crucially important. In this context, antibodies have been introduced as valuable tools in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clostridium difficile and Clostridium perfringens research
• Share to Toxin Mechanisms and Immunotoxins
• Share to Viral gastroenteritis research and epidemiology